Sent the following question to Investor Relations:
_________________
Dear Sirs,
I hope the new year finds you well and that business is progressing successfully at Medify Solutions.
I look forward to the upcoming investor update scheduled for this Monday, January 8th. I believe having a weekly exchange with investors will assist Medify in building confidence in your firm and its management.
With regard to the update, please provide a review of the Voice2Voice acquisition completed this past summer. As you recall, V2V was described as a successful, profitable company that would immediately and substantially contribute to Medify's revenues and profitability. Indeed, Mr. Bryant publically stated that he was leaving his executive position at Medify so that he might assume the leadership of V2V.
Specifically, I would appreciate if your update would address the following aspects of this acquisition.
First, please outline how V2V is currently contributing to Medify's revenues.
Secondly, please describe the financials of the acquisition itself. To date, it is unclear how Medify had the financial resources to complete this deal.
Thirdly, has Mr. Bryant assumed control of the company?
Finally, following the deal, has the V2V leadership assumed a management role at Medify Solutions as suggested in the PR. If so, who are they and what is their role.
Investors look forward to your response on these points.
Thank you
